PEPTOMYC

Developing a Myc inhibitor to treat Cancer. OMOMYC

[PEPTOMYC @peptomyc]

📍We're at #BIO2026 in San Diego!
Peptomyc's CEO @jesmartingarcia and CSO @LauraSoucek are attending the event as part of the 🇪🇸 Spanish Pavilion with @ICEX_, meeting partners and industry leaders to discuss innovation in oncology and therapies targeting MYC in cancers.

[PEPTOMYC @peptomyc]

#RAS showed the world that "undruggable" targets can be drugged.
We're honored to see a recent @Nature News & Views point to #MYC as a promising next frontier and to see @peptomyc mentioned among those moving the field forward.
The journey continues.
https://t.co/p5jbiq0Pdz

[PEPTOMYC @peptomyc]

Encouraging to see positive Phase 3 results with #daraxonrasib in previously treated mPDAC, where every meaningful advance matters. Milestones like this reinforce the value of pursuing bold science against difficult targets.
#RASi #MYCi
https://t.co/SChLYVp6F6

[PEPTOMYC @peptomyc]

Pleased to share that tomorrow, Wednesday, April 22, at #AACR2026 in San Diego, @ignigor will be presenting poster #7174. (Section 16, Board 6). Congratulations!
Work done by @VHIO, @icreacommunity & @peptomyc !
#Oncology #Immunotherapy #LungCancer #MYC #KRAS

[PEPTOMYC @peptomyc]

Excited to share that @dcapi14 is presenting today (April 20) at #AACR2026 exciting work on #MYC inhibition (#OMO-103) in KRAS-driven cancers. (Poster 1880). Work from @VHIO, @icreacommunity & @peptomyc !

[enisa @enisa]

#EmprendedorasEnisa @peptomyc alcanza 5 M€ para su fármaco contra el cáncer vía @diariARA

La #financiación servirá para completar los estudios clínicos en marcha.
https://t.co/AUX40omumV

[Laura Soucek @LauraSoucek]

Este sábado a las 21:30 @radio5_rne en el programa #Irrepetibles! Mil gracias @CarlesMesa por tu gran profesionalidad y por dar visibilidad a nuestra investigación en @VHIO, @icreacommunity y @peptomyc.

[PEPTOMYC @peptomyc]

Peptomyc closes €5 Million Equity Financing to advance OMO-103 toward the next stage of development.
Read the Press release here: https://t.co/p0kMbAmDmh

[PEPTOMYC @peptomyc]

Frontiers in Cancer Research and Therapy 2026 conference" hosted by @karolinskainst "in Stockholm. Our Co-founder & CSO, @LauraSoucek, delivered today a compelling talk pushing the boundaries of what’s possible in targeting one of the most challenging drivers in cancer. #Cancer

[PEPTOMYC @peptomyc]

Last Friday, @LauraSoucek, our CSO and co-founder, was invited as a speaker at the #PhDDay of the @IIBmCSICUAM, CIBERER / @IdiPAZScience in Madrid. She shared her insights, experiences, and perspective with the next generation of researchers.

[Laura Soucek @LauraSoucek]

Last Friday I was an invited speaker at the PhD Day of @IIBM_CSIC / CSIC-UAM / CIBERER / IdiPaz in Madrid.

I talked about the journey toward a clinically viable MYC inhibitor and my path as a researcher (@VHIO, @icreacommunity, @LSoucekLab) and entrepreneur (@peptomyc).

[PEPTOMYC @peptomyc]

New review out in @FrontImmunol! 🎉
@VHIO @icreacommunity @LSoucekLab and @peptomyc explore how the oncogene MYC drives immune evasion and resistance to cancer immunotherapy—and why targeting MYC could help restore antitumor immunity.
👉 https://t.co/a3SeIDnDdA

[ICREA Community @icreacommunity]

🗞️Una revisió publicada a @FrontCellDevBio
amb participació de l'#investigadorICREA @LauraSoucek (@VHIO @peptomyc), analitza com la combinació d'inhibidors oncogènics MYC amb teràpies dirigides obre noves oportunitats terapèutiques.
https://t.co/ptPrZpOHs8

[PEPTOMYC @peptomyc]

Back from San Francisco 🇺🇸
During #JPMHealthcare week, Peptomyc’s CEO @jesmartingarcia and CSO @LauraSoucek met with pharmaceutical partners to explore strategic collaborations.
Strong discussions, shared vision, and exciting next steps ahead.
📍 San Francisco
#Partnerships

[Laura Soucek @LauraSoucek]

🎉 New review in @FrontCellDevBio: #MYC in DNA damage response (#DDR) — driver of genomic instability and DNA repair.
Key idea: #MYC inhibition → DDR vulnerabilities → rational combos (#PARP, ATR/CHK1, WEE1).
🔗 https://t.co/jGmRAEYUfD
#MYC #DDR @VHIO @peptomyc @icreacommunity

[PEPTOMYC @peptomyc]

Wishing you a joyful holiday season!

[PEPTOMYC @peptomyc]

Ayer @LauraSoucek , nuestra CSO, participó como Keynote Speaker en la 19ª Jornada Científica y 29ª Conferencia Anual del Hospital Vall d’Hebron ✨
Agradecemos al @vallhebron por crear un espacio de intercambio tan enriquecedor.
https://t.co/6hdla6IXvW
#MYC #KeynoteSpeaker

[PEPTOMYC @peptomyc]

Nos complace compartir que la Dra. @LauraSoucek participó ayer, miércoles 3 de diciembre, como ponente en la XV edición del @CNIOStopCancer Lab Day, aportando su visión científica y emprendedora. Muchas gracias al equipo organizador! @msmelanoma

[PEPTOMYC @peptomyc]

Groundbreaking research advances OMO-103 as a potential combination therapy for treatment-resistant breast cancer. Fabio Giuntini & @LauraSoucek

Read the full publication: https://t.co/9bXpBwqxZ4

[Laura Soucek @LauraSoucek]

Link to the article: MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer: Cell Reports

[Laura Soucek @LauraSoucek]

Huge thanks to Fabio Giuntini, and to the entire teams at @VHIO and @peptomyc for making this possible. We also want to acknowledge the support of @CMMetastasico and the @ERC_Research for backing research that can make a real difference.